NCT00987272

Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects

A Phase III Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the CAC Model of Acute Allergic Conjunctivitis in Japanese Subjects

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 267 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to demonstrate safety and efficacy of Olopatadine 0.2% compared to its vehicle in Japanese subjects in the treatment of acute allergen-mediated conjunctivitis using the conjunctival allergen challenge (CAC) test.

Conditions

• Allergic Conjunctivitis

Interventions

Type	Name	Description
DRUG	Olopatadine Hydrochloride Ophthalmic Solution, 0.2%
DRUG	Olopatadine Hydrochloride Ophthalmic Solution, 0.1%
DRUG	Olopatadine 0.2% Vehicle	Inactive ingredients used as placebo comparator
DRUG	Olopatadine 0.1% Vehicle	Inactive ingredients used as placebo comparator

Timeline

• Start date: 2009-10-01
• Primary completion: 2009-11-01
• Completion: 2009-11-01
• First posted: 2009-09-30
• Last updated: 2014-07-31